Blog
RSS FeedPosted by Michael Wonder on 20 Mar 2023
Resignations at Canada’s drug pricing panel raise independence questions
14 March 2023 - A member of Canada’s drug pricing regulator has resigned, stating the federal government has undermined the ...
Posted by Michael Wonder on 19 Mar 2023
Lower drug prices are a good thing. Canada’s approach to achieving them was not.
17 March 2023 - Over the past six years, the Patented Medicine Prices Review Board – Canada’s federal drug-price regulating agency ...
Posted by Michael Wonder on 16 Mar 2023
First drugs facing Medicare price penalty are named
15 March 2023 - US lists 27 medications whose prices rose faster than inflation, triggering rebates under new law. ...
Posted by Michael Wonder on 15 Mar 2023
HHS releases initial guidance for historic Medicare drug price negotiation program for price applicability year 2026
15 March 2023 - For the first time, Medicare will be able to negotiate prices directly with drug companies, ensuring ...
Posted by Michael Wonder on 15 Mar 2023
Inflation Reduction Act tamps down on prescription drug price increases above inflation
15 March 2023 - HHS announces savings for some people with Medicare on 27 Part B prescription drugs. ...
Posted by Michael Wonder on 15 Mar 2023
MHRA to receive £10 million from HM Treasury to fast track patient access to cutting edge medical products
15 March 2023 - A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency to ...
Posted by Michael Wonder on 15 Mar 2023
EMA-FDA parallel scientific advice program has ‘limited’ uptake
14 March 2023 - A review of the last five years of the parallel scientific advice program between the FDA ...
Posted by Michael Wonder on 14 Mar 2023
BMS, Pfizer, AbbVie drugs likely to face US price negotiation
13 March 2023 - The blood thinner Eliquis from BMS, Pfizer's breast cancer drug Ibrance and AbbVie's leukaemia treatment Imbruvica ...
Posted by Michael Wonder on 10 Mar 2023
Medicare will take R&D costs, effectiveness into account when it negotiates drug prices. But studies show that doesn’t affect prices.
10 March 2023 - By law, Medicare will have to take a medication’s efficacy and its research and development costs ...
Posted by Michael Wonder on 09 Mar 2023
Patent system key to lower drug prices, experts say
9 March 2023 - Following the Biden administration’s progress towards lowering prescription drug prices with Medicare price negotiations, some industry ...
Posted by Michael Wonder on 08 Mar 2023
Preterm birth drug withdrawn after 12 years
7 March 2023 - The FDA seemed poised to rescind approval of Makena, after studies over time indicated the treatment did ...
Posted by Michael Wonder on 08 Mar 2023
The unique device identifier: a unique opportunity
7 March 2023 - A unique device identifier is an individualised alphanumeric signature associated with a single medical device. Since 2013, ...
Posted by Michael Wonder on 08 Mar 2023
In Amsterdam, EU drugs regulator doesn’t want brothel moving in next door
7 March 2023 - Sex and drugs don’t mix, argues the EMA. ...
Posted by Michael Wonder on 03 Mar 2023
Bipartisan senators introduce bill to close pharma competition loophole
1 March 2023 - Senators Maggie Hassan and Mike Braun on Wednesday reintroduced legislation intended to close a loophole that ...
Posted by Michael Wonder on 03 Mar 2023
Health minister disputes claim he sided with big pharma, interfered with drug price consultations
1 March 2023 - Review board 'will never be subjected to political interference,' Duclos said. ...